In vivo efficacy, toxicity and biodistribution of ultra-long circulating desferrioxamine based polymeric iron chelator
- 1 September 2016
- journal article
- Published by Elsevier BV in Biomaterials
- Vol. 102, 58-71
- https://doi.org/10.1016/j.biomaterials.2016.06.019
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council
- Canada Foundation for Innovation
- Michael Smith Foundation for Health Research
- Saskatchewan Health Research Foundation
This publication has 43 references indexed in Scilit:
- Polymeric nanocarriers for the treatment of systemic iron overloadMolecular and Cellular Therapies, 2015
- The Pathophysiology of Transfusional Iron OverloadHematology/Oncology Clinics of North America, 2014
- How I treat transfusional iron overloadBlood, 2012
- Iron-Chelating Therapy for Transfusional Iron OverloadThe New England Journal of Medicine, 2011
- Soluble Polymer Carriers for the Treatment of Cancer: The Importance of Molecular ArchitectureAccounts of Chemical Research, 2009
- PEGylation, successful approach to drug deliveryDrug Discovery Today, 2005
- Reduction of Drug Toxicity Using Dendrimers Based on MelamineMolecular Pharmaceutics, 2004
- The dawning era of polymer therapeuticsNature Reviews Drug Discovery, 2003
- Iron poisoning in childrenCurrent Opinion in Pediatrics, 1994
- Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers.Proceedings of the National Academy of Sciences of the United States of America, 1989